Article Text

other Versions

Download PDFPDF
Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials
  1. Greta Dreyer1,
  2. Matthys H Botha2,
  3. Leon C Snyman1,
  4. Cathy Visser1,
  5. Riekie Burden3,
  6. Nicolene Laubscher4,
  7. Bertha Grond3,
  8. Karin Richter5,
  9. Piet J Becker6,7,
  10. Justin Harvey8 and
  11. Frederick H van der Merwe2
  1. 1Obstetrics and Gynaecology, University of Pretoria Faculty of Health Sciences, Pretoria, South Africa
  2. 2Obstetrics and Gynaecology, University of Stellenbosch, Stellenbosch, South Africa
  3. 3HPV Cervical Cancer Research Fund, Pretoria, South Africa
  4. 4HPV Cervical Cancer Research Fund, Cape Town, South Africa
  5. 5Medical Virology, University of Pretoria Faculty of Health Sciences, Pretoria, South Africa
  6. 6Faculty Research Office, University of Pretoria Faculty of Health Sciences, Pretoria, South Africa
  7. 7Biostatistics Unit, South African Medical Research Council, Pretoria, South Africa
  8. 8Centre for Statistical Consultation, University of Stellenbosch, Stellenbosch, South Africa
  1. Correspondence to Professor Greta Dreyer, Obstetrics and Gynaecology, University of Pretoria Faculty of Health Sciences, Pretoria, Gauteng, South Africa; gretadreyer{at}mweb.co.za

Abstract

Objective The platform provided by human papillomavirus (HPV) vaccination for linked public health interventions to improve cervical cancer prevention remains incompletely explored. The Vaccine And Cervical Cancer Screen (VACCS) cross-sectional observation trials aimed to evaluate the efficacy of school-based HPV vaccination linked with maternal cervical cancer screening.

Methods Girls from 29 schools in two provinces in South Africa were invited in writing to receive HPV vaccination. Two approaches to informed consent were compared, namely an audiovisual presentation (VACCS1) and in written format (VACCS2). Markers of vaccine uptake and coverage were calculated, namely uptake among the invited and consented cohorts, and rates of completion and sufficient vaccination. Mothers and female guardians received educational material about cervical cancer, and either a self-sampling device or an invitation to attend existing screening facilities. Knowledge was assessed via structured questionnaires (before and after), and screening uptake was self-reported and directly assessed and compared between these approaches.

Results Vaccine acceptance among 5137 invited girls was similar for the two methods of consent; 99.3% of consented girls received a first dose; overall completion rate was 90.5%. More girls were vaccinated using a two-dose (974/1016 (95.9%)) than a three-dose regimen (1859/2030 (91.6%)). The questionnaire (n=906) showed poor maternal knowledge which improved significantly (p<0.05) after health education; only 54% of mothers reported any previous screening. The offer of a self-sampling device (n=2247) was accepted by 43.9% of mothers, but only 26% of those invited to screen at existing facilities (n=396) reported subsequent screening.

Conclusions Successful linking of primary health interventions to control cervical cancer was demonstrated. School-based HPV vaccination, linked to health education, self-sampling, and molecular screening resulted in significant improvements in knowledge and screening.

  • cervical cancer

Data availability statement

Data are available upon reasonable request.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request.

View Full Text

Footnotes

  • Contributors GD, MHB, BG, and FHvdM designed the studies. LCS and FHvdM coordinated sites. CV coordinated the study and collated data. RB collected data. NL coordinated vaccination. BG coordinated vaccine donations. KR coordinated screening. PJB and JH performed statistical analysis. GD drafted the paper and acts as guarantor. MHB, LCS, CV, BG, and FHvdM reviewed the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.